Protocol for a randomised trial on the effect of group education on skin-protective behaviour versus treatment as usual among individuals with newly notified occupational hand eczema - the Prevention of Hand Eczema (PREVEX) Trial.

ABSTRACT:

Background

The incidence of occupational hand eczema is approximately 0.32 per 1,000 person years. The burden of the disease is high, as almost 60% has eczema-related sick leave during the first year after notification, and 15% are excluded from the workforce 12 years after disease onset. New treatments and prevention strategies are needed.

Methods/design

Trial design

The PREVEX trial is a randomised, parallel-group, superiority trial.

Participants

All individuals from the Capital Region of Denmark and Region Zealand with a suspected occupational skin disorder notified to the National Board of Industrial Injuries between June 2012 and December 2013 are invited to participate in the trial. Inclusion criteria are: self-reported hand eczema and informed consent.

SUBMITTER: Fisker MH 

PROVIDER: S-EPMC4225615 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature